

Author: Kimura K. Ishihara K. Tagawa T. Sakurai M. Fujii Y. Dote S. Naruse T. Sasa M. Namba K.
Publisher: Elsevier
ISSN: 0306-3623
Source: General Pharmacology, Vol.27, Iss.1, 1996-01, pp. : 73-77
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content










CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 4, 2009-08 ,pp. :